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Abstract The effects of different bioactive sphingoid molecules 
on NOS activity of differentiated cerebellar granule cells were 
investigated by measuring the conversion of [3Hlarginine to 
[3H]citruUine. Cytosolic Ca2+-dependent NOS activity was 
strongly inhibited in a dose-dependent manner by sphingosine 
in concentrations of 1-40 gM. This inhibition seems to be 
peculiar to sphingosine in that ceramide, N-acetylsphingosine, 
sphingosine-lP, sphinganine and tetradecylamine have no effect 
on the cytosolic enzyme at the considered concentrations, 
suggesting that it is the bulk of the sphingosine hydrophilic 
portion that is critical for cytosolic NOS inhibition. This 
inhibition of cytosolic NOS is not reversed by increasing the 
arginine concentration, so a competitive mechanism can be 
excluded. Instead, increasing the concentrations of calmodulin 
led to loss of sphingosine inhibition, suggesting that sphingosine 
interferes with the calmodulin-dependent activation of the 
enzyme by a competitive mechanism. Sphingosine and related 
compounds had no effect on the particulate Ca2+-independent 
NOS activity. The data obtained suggest hat sphingosine could 
be involved in the regulation of NO production in neurons. 
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1. Introduction 
Studies on several cell types have brought o light evidence 
that specific sphingoid molecules, mainly ceramide, sphingo- 
sine and sphingosine-l-phosphate, r  involved in the mecha- 
nism of cell response to different extracellular agents (for re- 
views, see [1-4]). This signalling mechanism is emerging as a 
complex one, which can operate both by affecting direct intra- 
cellular targets (including specific protein kinases and phos- 
phatases) and, interestingly, by cross-talking with other sig- 
nalling pathways. Also in nervous system cells it has been 
revealed [5 l l] that sphingoid molecules act as intracellular 
mediators of the effects of specific stimuli, especially with 
regard to neuronal differentiation [5-7,10,11]. In fact, the ad- 
ministration of differentiating agents to neuroblastoma cells 
results in increased intracellular ceramide which in turn acts 
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Abbreviations." BH4, (6R)-5,6,7,8-tetrahydrobiopterin; BME, basal 
nodified Eagle's medium: BSA, bovine serum albumin; CaM, calmod- 
ulin; Cer, ceramide; C2-Cer, N-acetylsphingosine; FCS, fetal calf 
serum; NO, nitric oxide; NOS, NO synthase; iNOS, inducible NO 
synthase; Sa, sphinganine; Smase, sphingomyelinase; Sph, sphingo- 
sine; Sph-lP, sphingosine-l-phosphate; TdA, tetradecylamine 
as a mediator of their neuronal-like differentiation [7]. Further 
evidence supporting sphingoid molecule involvement in neu- 
ronal differentiation lies in the fact that in primary cultures of 
cerebellar granule cells the cellular content of both ceramide 
and sphingosine increases throughout heir differentiation i  
culture, and is maintained at high levels in differentiated cells 
[10]. 
From among the different signalling pathways operating in 
the nervous system, one that is peculiar is that mediated by 
nitric oxide (NO), a highly diffusible, short-lived messenger 
involved in the modulation of several neural functions, includ- 
ing neurotransmission a d differentiation [12-16]. In a pre- 
vious study [17] we demonstrated that cerebellar granule cells 
contain a cytosolic Ca2+-dependent NO synthase (NOS) ac- 
tivity and a particulate one that is almost Ca2+-independent, 
and that these enzymes progressively and markedly increase 
during differentiation; such an enzyme increase represents a 
specific expression of differentiated cells. 
The involvement of sphingoid molecules and NO in differ- 
entiating cerebellar granule cells prompted us to investigate 
the possible occurrence of cross-talk between the sphingoid 
and the nitric oxide signalling pathways in these neurons. 
As a first approach we studied the possible effects of different 
bioactive sphingoid molecules on NOS activity in differenti- 
ated cerebellar granule cells, and we observed a specific inhib- 
itory effect of sphingosine on cytosolic Ca2+-dependent NOS 
activity, likely due to competition with calmodulin, the known 
physiological activator of the enzyme. 
2. Materials and methods 
2.1. Materials 
Basal modified Eagle's medium (BME), fetal calf serum (FCS), 
NADPH tetrasodium salt, (6R)-5,6,7,8-tetrahydrobiopterin dihydro- 
chloride (BH4), arginine, HEPES, EGTA, ceramide from bovine brain 
sphingomyelin (Cer), D-erythro-sphingosine (Sph), sphingosine-1- 
phosphate (Sph-lP), D-etTthro-sphinganine (Sa), N-acetyl sphingosine 
(C2-Cer), tetradecylamine (TdA), bovine brain calmodulin (CAM), 
were from Sigma (St. Louis, MO, USA); HPTLC silica gel plates 
from Merck (Darmstadt, Germany); L-[2,3,4,5-3H]arginine monohy- 
drochloride (64 Ci/mmol) from Amersham (Bucks, UK); Coomassie 
protein assay reagent and bovine serum albumin (BSA) from Pierce 
Chemical Co. (Rockford, IL, USA). 
2.2. Cell cultures 
Primary cultures of granule cells were prepared from cerebella of 
8 day old rats (Sprague-Dawley) and cultured in 60 mm dishes, in a 
humidified atmosphere of 5% CO2 and 95% air at 37°C with 5 ml of 
BME medium supplemented with 10% FCS as previously described 
[18]. After 9 days in culture the cells, represented by >-95% differ- 
entiated granule neurons, were rinsed twice with 50 mM HEPES (pH 
7.4), 2.7 mM KC1 and 100 mM NaC1, scraped off the plates in the 
same buffer solution (0.2 ml/dish) with a rubber policeman and 
homogenized by gentle pipetting up and down 50 times. The homog- 
enates were centrifuged at 100 000 ×g (30 rain at 4°C) and the super- 
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natant and sedimented pellet collected and used respectively as the 
cytosolic and particulate tractions. Before use, the pellet was homoge- 
neously suspended with 0.2 ml of the above buffer solution. 
2.3. Determination of NOS activity 
NOS activity was determined on fresh cytosolic and particulate 
fractions by measuring the conversion of [3H]arginine to 
[3H]citrulline. The assay was performed according to Bredt and 
Snyder [19] with some modifications [17] as follows: 10 gg protein 
of cytosolic fraction was incubated at 37°C for 60 min in 50 gl 0.45 
mM CaCI2, 2 mM NADPH, 10 gM BH4, 50 mM HEPES buffer, pH 
6.4, and in the presence of different concentrations (4-12 gM) of 
[3H]arginine carrying 2 Ci/mmol. NOS activity on the particulate 
fraction was assayed both in the same reaction conditions used for 
cytosolic enzyme, or replacing CaCI2 by 1 mM EGTA. Samples were 
then processed as previously described [17]. The enzyme activity, ex- 
pressed as nmol [3H]citrulline mg -1 protein h 1, was calculated as 
previously described [17]. With both enzymes, and as established by 
ad hoc experiments, enzyme saturation was achieved with 10 laM 
arginine. 
2.4. Eff~ct of different sphingoid molecules and long cha& all~'ylamines 
on NOS activity 
The effect of different sphingoid molecules and tetradecylamine 
(TdA) was evaluated by measuring cytosolic and particulate NOS 
activity in the presence of different concentrations (1M0 gM) of 
each molecule. For this purpose stock solutions of Sph, Sph-lP, Sa, 
TdA in absolute thanol were diluted in the enzyme suspension buffer 
(50 mM HEPES, 2.7 mM KC1, 100 mM NaC1, pH 6.4): 5 #1 of the 
obtained solutions was added to 40 ~al of the enzyme suspension and 
preincubated for 10 min at 4°C (ethanol final concentration i the 
enzyme assay <0.5%, v/v). The enzymatic reaction was then started 
by the addition of 5 gl of a mixture containing CaCI_,, NADPH, BH4 
and [3H]arginine. When Cer and C2-Cer were used, stock solutions 
were prepared in ethanol/dodecane 98/2 (v/v) [20]. then diluted and 
added to the enzyme suspensions as described above. Control experi- 
ments showed that the used concentrations of ethanol and ethanol/ 
dodecane did not affect NOS activity. 
2.5. Efli, ct of  sphingosine on ~;vtosolic NOS activity in the presence of 
exogenously added calmodulin 
The possible interactions between Sph and CaM, the known phys- 
iological activator of cytosolic NOS [21], were studied using the ex- 
perimental conditions described in Section 2.4. CaM at different con- 
centrations (0.06 6 ftM) was added during the preincubation together 
with Sph, and the enzymatic reaction started as described above. 
2.6. Protein determination 
Protein content in the cytosolic and particulate fractions was deter- 
mined with the Coomassie protein assay reagent using BSA as the 
standard. 
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3. Results 
As our aim was to evaluate the possible influence of sphin- 
gold molecules on NOS activity in differentiated granule cells, 
we first considered ceramide and sphingosine, two bioactive 
sphingoids present at high levels in these cells differentiated in
culture [10]. Cerebellar granule cells used on the 9th day in 
culture showed a cytosolic NOS activity which is Ca2+-de - 
pendent and a particulate one which is Ca2+-independent 
[17]; in particular NOS activity assayed in the cytosolic frac- 
tion was 6.7 + 0.9 nmol mg 1 protein h - I ,  and was abolished 
by the presence of I mM EGTA. On the other hand, NOS 
activity evaluated on the particulate fraction was 1.4_+0.2 
nmol mg -I protein h I the same value being obtained in 
the presence of either 1 mM EGTA or 0.45 mM CaC12. Using 
10 gg protein of the cytosolic or particulate fraction, we found 
that Sph exerted a strong dose-dependent inhibitory effect on 
Ca2+-dependent cytosolic NOS, reaching 80% and 95% inhib- 
ition at 20 and 40 gM respectively (Fig. 1, left panel). In 
contrast, concentrations up to 40 gM of Sph had no effect 
on the activity of the CaZ+-independent particulate NOS as- 
sayed in presence of 1 mM EGTA (Fig. 1, right panel). At  all 
the used concentrations Sph did not influence particulate NOS 
even when the enzyme assay was performed in the presence of 
0.45 mM CaC12. Under the same experimental conditions Cer 
(up to 40 gM) did not modify the activity of either enzyme. 
The potent inhibitory effect of sphingosine on cytosolic 
NOS, prompted us to evaluate the effects of different Sph 
analogues, namely its phosphorylated metabolite Sph-lP,  N- 
acetyl derivative (C2-Cer), the saturated stereoisomer D-eryth- 
ro-sphinganine (Sa), and the long chain alkylamine tetradecyl- 
amine (TdA) on the same enzyme. As shown in Fig. 2, at both 
10 and 20 gM concentration, one of these molecules had any 
significant effect on cytosolic NOS activity; nor was any effect 
observed at 40 gM effector. Also, the activity of the particle- 
bound NOS remained unaffected by these molecules, under 
the same experimental conditions (data not shown). 
In order to explore the mechanism by which Sph interferes 
with cytosolic NOS, a kinetic analysis of the enzyme activity 
was carried out in the presence or absence of 10 gM Sph (Fig. 
3). Sph was found to decrease the apparent Vm~x of the en- 
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Fig. 1. Influence of sphingosine and ceramide on cytosolic and particulate NOS activity of cerebellar granule cells. NOS activity was determined 
in the presence of different concentrations of Sph or Cer (0 20 gM) as described in Section 2. Data are the mean values of at least three ex- 
periments, each in duplicate; S.D. never exceeded 15% of the mean. 
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Fig. 2. Influence of different sphingoid molecules and long chain al- 
kyl amines on cytosolic NOS activity of cerebellar granule cells. The 
cytosolic NOS activity was determined in the presence of 10 ~tM 
(panel A) and 20 pM (panel B) of none (A), Sph (B), Sph-lP (C), 
Sa (D), TdA (E), or C2-Cer (F). Data are the mean values + S.D. of 
at least three experiments in duplicate. 
zyme with no alteration of Km values, indicating a non-com- 
petitive inhibition. 
It is well known that Ca2+-promoted CaM binding is re- 
quired for the activity of cytosolic neuronal NOS, including 
cerebellar granule cell NOS activity [21]; thus we measured 
the effect of Sph on this enzyme in the presence of different 
concentrations of CaM. In the absence of Sph NOS activity 
was not appreciably affected by CaM (Fig. 4), whereas in the 
presence of Sph increasing the concentration of CaM (from 
0.06 to 6 ~aM) led to the loss of the Sph inhibitory effect in a 
dose-dependent manner. Sph concentrations determining a
50% inhibition of NOS were 10, 15, 20 btM in presence of 
no, 0.06 and 0.6 btM exogenously added CaM, respectively. 
4. Discussion 
Previous studies on the effect of sphingoid molecules on the 
NO signalling pathway mainly regarded the cytokine-medi- 
ated iNOS expression in non-neuronal tissues or cells [22 
25]. In addition, it has been reported that ceramide-induced 
vasodilation in rat thoracic aortic rings is partially dependent 
on endothelium-derived NO [26], and that sphingosine and 
SMase treatment significantly attenuates endothelium-depend- 
ent relaxation in response to different stimuli in coronary 
arteries [27]. 
In this study we provide evidence that sphingosine xerts a 
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Fig. 3. Kinetic analysis of sphingosine inhibition of cytosolic NOS 
activity. The enzyme was assayed alone (O) or with 10 btM sphingo- 
sine (• )  in the presence of different concentrations of arginine (4 
12 gM). Data are the mean values of at least three experiments in
duplicate; S.D. never exceeded 15% of the mean. 
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Fig. 4. Effect of sphingosine on cytosolic NOS activity of cerebellar 
granule cells: influence of calmodulin. 10 gg of cytosolic enzyme 
was incubated in the presence of both sphingosine (5 20 btM) and 
calmodulin 0 (m), 0.06 (0), 0.6 (A) and 6 (O) btM. Data are the 
mean values of at least three experiments in duplicate; S.D. never 
exceeded 15% of the mean. 
significant dose-dependent inhibitory effect on the in vitro 
NOS activity associated with the cytosolic fraction of differ- 
entiated cerebellar granule cells, but does not influence the in 
vitro activity of the particulate Ca 2+-independent e zyme. Sph 
concentrations effective on NOS are similar to or lower than 
those used in previous studies that demonstrated an in vitro 
modulatory effect of Sph on different enzymes ([28,29] and 
references in [4]). The inhibition exerted by sphingosine ap- 
pears to be specific and to require the bulk of the hydrophilic 
portion of the molecule. In fact, N-acylated sphingosine, Cer, 
the metabolic precursor of sphingosine, and the water-soluble 
analog C2-Cer are not effective in modulating the activity of 
cytosolic NOS, thus indicating that the amino group of Sph is 
necessary for its inhibitory activity on NOS. The amino group 
is not the only requirement for the Sph-mediated inhibition of 
NOS since the long chain alkylamine, TdA, is also inefficient 
as inhibitor of cytosolic NOS. Furthermore, sphingosine 
phosphorylated at C-1 (Sph-lP), a bioactive molecule [30] 
intermediate in Sph catabolism [31], does not modify cytosolic 
NOS activity, indicating that the primary hydroxyl function is 
also required for Sph inhibitory activity on NOS. Also the 
sphingolipid metabolic precursor sphinganine, which differs 
from sphingosine in that it lacks the double bond between 
C4 and C5, is without effect, suggesting that NOS inhibition 
by sphingoid bases is also sensitive to the presence of the 
sphingosine double bond. Kinetic experiments demonstrate 
that Sph decreases the apparent maximal velocity but does 
not alter the apparent Km value, thus acting as a non-com- 
petitive inhibitor of NOS. 
Finally the possibility that cytosolic NOS inhibition by 
sphingosine is linked to NOS activity dependence on CaM 
was investigated. The results we obtained demonstrate that 
increasing concentrations of CaM promote a rightward shift 
of the Sph-dependent inhibition curve of cytosolic NOS, in- 
dicating that Sph interferes with the CaM-dependent activa- 
tion of the enzyme, presumably by a competitive mechanism. 
This result is in agreement with previous studies that demon- 
strate that Sph is able to inhibit other CaM-dependent en- 
zymes [32]. Since in the enzyme assay Sph is always present 
at much higher concentrations than CaM, it is unlikely that 
calmodulin simply lowers the effective concentration of Sph 
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by acting as a Sph binding protein. The Sph inhibitory activ- 
ity could be explained either by a binding of Sph to the Ca- 
calmodulin complex or by its interaction with the calmodulin 
binding domain of cytosolic NOS. The evidence that Sph 
interferes with the CaM activation of cytosolic NOS could 
also explain the Sph failure to inhibit the CaX+-independent 
NOS activity associated to the particulate fraction of cerebel- 
lar granule cells. 
In conclusion, the data obtained demonstrate that sphingo- 
sine, but not other structurally related bioactive sphingoid 
molecules like ceramide, sphingosine-lP and sphinganine, is 
able to modulate the Ca2+-dependent NOS of cerebellar neu- 
rons, possibly through a CaM-dependent mechanism. The 
physiological relevance of these results derives from the evi- 
dence that sphingosine cellular concentrations have been 
found in the micromolar ange in different cell types (reviewed 
in [33]) and sphingosine intracellular levels can rapidly and 
transiently increase in response to extracellular stimuli (re- 
viewed in [34]). To the best of our knowledge, this is the first 
evidence suggesting the involvement of Sph in the regulation 
of NO production in neurons, implying the occurrence of 
cross-talk between sphingolipid- and NO-mediated pathways 
of signal transduction operating in these cells. The occurrence 
of NOS inhibition by sphingoid bioregulators in in vivo sys- 
tems is under current investigation in our laboratory. 
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